Auteurs: Philippe Beutels (Centre for Health Economics Research & M
odelling Infectious Diseases (CHERMID), Vaccine &
Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & M
odelling Infectious Diseases (CHERMID), Vaccine &
Infectious Disease Institute, University of Antwer
...[+++]p), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Wetenschappelijk Instituut Volksgezondheid), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Christelijke Mutualiteit), Michael Callens (Christelijke Mutualiteit), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).Auteurs : Philippe Beutels (Centre for Health Economics Research & M
odelling Infectious Diseases (CHERMID), Vaccine &
Infectious Disease Institute, University of Antwerp), Adriaan Blommaert (Centre for Health Economics Research & M
odelling Infectious Diseases (CHERMID), Vaccine &
Infectious Disease Institute, University of Antwe
...[+++]rp), Germaine Hanquet (KCE), Joke Bilcke (Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, University of Antwerp), Nancy Thiry (KCE), Martine Sabbe (Institut Scientifique de Santé Publique), Jan Verhaegen (Dept Microbiologie, UZ Leuven), Frank De Smet (Mutualité chrétienne), Michael Callens (Mutualité chrétienne), Pierre Van Damme (Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp).
